Breakout Labs, investor Peter Thiel’s nonprofit fund for science startups, has provided $350,000 grants to three early-stage health companies. The recipients include: Cortexyme, which is focused on treatments for Alzheimer’s and other neurological disorders; G-Tech Medical, which is developing an “EKG for the gut” to determine the root cause of gastrointestinal disorders; and EpiBone, which is attempting to use stem cells to create “patient-specific bone tissue replacement.” Breakout Labs generally awards grants from $50,000 to $350,000. The companies, in turn, provide a “modest royalty stream” used to fund additional startups.
This article originally appeared on Recode.net.
Will you support Vox’s explanatory journalism?
Most news outlets make their money through advertising or subscriptions. But when it comes to what we’re trying to do at Vox, there are a couple reasons that we can't rely only on ads and subscriptions to keep the lights on.
First, advertising dollars go up and down with the economy. We often only know a few months out what our advertising revenue will be, which makes it hard to plan ahead.
Second, we’re not in the subscriptions business. Vox is here to help everyone understand the complex issues shaping the world — not just the people who can afford to pay for a subscription. We believe that’s an important part of building a more equal society. We can’t do that if we have a paywall.
That’s why we also turn to you, our readers, to help us keep Vox free. If you also believe that everyone deserves access to trusted high-quality information, will you make a gift to Vox today?
Yes, I'll give $5/month
Yes, I'll give $5/month
We accept credit card, Apple Pay, and
Google Pay. You can also contribute via